Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanib

Idiopathic pulmonary fibrosis (IPF) is the most common type of idiopathic interstitial pneumonia and is characterized by a poor prognosis, with an estimated 5-year survival of approximately 20%. Progressive and irreversible lung functional impairment leads to chronic respiratory insufficiency with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonella, Francesco, Stowasser, Susanne, Wollin, Lutz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4686227/
https://www.ncbi.nlm.nih.gov/pubmed/26715838
http://dx.doi.org/10.2147/DDDT.S76648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4686227/
https://www.ncbi.nlm.nih.gov/pubmed/26715838
http://dx.doi.org/10.2147/DDDT.S76648

Ejemplares similares